Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) shares saw unusually-high trading volume on Tuesday. 500,977 shares traded hands during mid-day trading, an increase of 160% from the previous session’s volume of 192,975 shares. The stock last traded at $11.7863 and had previously closed at $11.72.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two analysts have rated the stock with a Hold rating. According to MarketBeat.com, Sysmex presently has a consensus rating of “Hold”.

Check Out Our Latest Report on SSMXY

Sysmex Price Performance

The company has a quick ratio of 2.53, a current ratio of 3.40 and a debt-to-equity ratio of 0.23. The company’s 50 day moving average is $11.89 and its 200 day moving average is $10.03. The firm has a market capitalization of $7.01 billion, a price-to-earnings ratio of 27.45 and a beta of 1.18.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its quarterly earnings results on Friday, August 7th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. The business had revenue of $825.85 million for the quarter, compared to analyst estimates of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, equities research analysts anticipate that Sysmex Corporation ADR will post 0.41 earnings per share for the current fiscal year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.

Further Reading

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.